Worldwide, 3-year, Post-Marketing Surveillance Experience with Tofacitinib in Rheumatoid Arthritis
Rheumatol Ther 2018 Jun; 5(1):283–91
View and download slide summaries of the latest original articles focusing on therapies in immune-mediated inflammatory diseases including rheumatology, dermatology, and gastroenterology. All materials produced by the team are subsequently reviewed and approved by individual Steering Committee members.
Rheumatol Ther 2018 Jun; 5(1):283–91
Please click the links below to go to the CSF review of each paper.
Rheumatology (Oxford). 2018 Mar 1;57(3):499-507. DOI: 10.1093/rheumatology/kex443
J Rheumatol 2018 Apr; 45(4):456-464
Rheumatology (Oxford) 2017 Dec 1;56(12):2179-2189 doi: 10.1093/rheumatology/kex319
J Rheumatol 2018 Feb; 45(2):177-87
Nat Rev Drug Discov 2017;16:843–62 DOI: 10.1038/nrd.2017.201
Arthritis Rheumatol 2017;69(10):1960–68
N Engl J Med 2017; 377:1537-50. DOI: 10.1056/NEJMoa1615975
N Engl J Med 2017;377:1525–36.